Pulse Biosciences appoints chief medical officer
- Pulse Biosciences (NASDAQ:PLSE) appoints Gansevoort “Gan” Dunnington, M.D. as its CMO.
- Dr. Dunnington is a cardiothoracic surgeon and the Director of Cardiothoracic Surgery at St. Helena Hospital.
- Prior to his time at St. Helena Hospital, Dr. Dunnington was an assistant professor at Stanford University and assistant director of cardiothoracic surgery at El Camino Hospital, a Stanford University affiliate.